We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Louisiana's Department of Health announced that Merck & Co., AbbVie and Gilead Sciences are interested in the state's plan to use a Netflix-style subscription model to buy access to hepatitis C drugs for Medicaid patients and prisoners, as reported in the